Literature DB >> 6230399

Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.

G S Deepe, S R Watson, W E Bullock.   

Abstract

Disseminated infection with Histoplasma capsulatum stimulates the production of a suppressor factor (SF-H) by spleen cells from C3H/HeJ mice and a helper factor (HF-H) by spleen cells from C57BL/6 mice. In the present study these disparate immunoregulatory factors were analyzed in detail with regard to: a) the surface phenotype of the cells that produce SF-H and HF-H; b) the role of accessory cells in the production of these factors; and c) the surface phenotype of the target cells activated by SF-H and HF-H. Treatment of spleen cells from Histoplasma-infected C3H/HeJ mice with anti-Thy-1.2 plus complement (C) or with anti-Ly-2 plus C or with anti-I-Jk antiserum plus C abolished production of SF-H. Conversely, generation of HF-H by spleen cells from C57BL/6 mice was abrogated by treatment with either anti-Thy-1.2 plus C or with anti-Ly-1 plus C. Thus, a Thy-1.2+, Ly-2+, I-J+ T cell releases SF-H, and a Thy-1.2+, Ly-1+ T cell secretes HF-H. Production of SF-H and HF-H by splenic T cells was reduced markedly by depletion of macrophages (M phi); readdition of 1% syngeneic, plastic-adherent splenocytes from normal or infected mice to M phi-depleted, splenic T cell cultures of either strain restored the capacity to generate immunoregulatory factors. Furthermore, adherent splenocytes from normal or infected mice liberated a factor or factors that enhanced production of both SF-H and HF-H. Kinetic studies demonstrated that activation of normal spleen cells required at least 48 hr of exposure to SF-H or HF-H. Both factors failed to activate splenocytes pretreated with anti-Thy-1.2 plus C. Spleen cells from C3H/HeJ mice depleted of Ly-1+, Ly-2+, or I-J+ cells and exposed to SF-H did not demonstrate suppressor activity, whereas Ly-1-depleted splenocytes from C57BL/6 mice exposed to HF-H failed to exert helper activity. Therefore, the target of SF-H is a Thy-1.2+, Ly-1+2+, I-J+ T cell, and the target of HF-H is a Thy-1.2+, Ly-1+ T cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230399

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.

Authors:  R A Cox; W Kennell; L Boncyk; J W Murphy
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 2.  Immunological aspects of fungal pathogenesis.

Authors:  G S Deepe; W E Bullock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

3.  Modifications of the immune response induced by Histoplasma capsulatum products.

Authors:  B H Ruiz; R E Carvajal; L Ortiz-Ortiz
Journal:  Mycopathologia       Date:  1990-01       Impact factor: 2.574

4.  Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Authors:  Y Wang; S P Li; S A Moser; K L Bost; J E Domer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis.

Authors:  M F Fojtasek; M R Sherman; T Garringer; R Blair; L J Wheat; C T Schnizlein-Bick
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.

Authors:  R L Mosley; J W Murphy; R A Cox
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2.

Authors:  G S Deepe; C L Taylor; J E Harris; W E Bullock
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

8.  Immunosuppression transfer by spleen cells from young to adult mice previous to Histoplasma capsulatum infection.

Authors:  M R Reyes-Montes; M P García-Camacho; J Casasola; M L Taylor
Journal:  Mycopathologia       Date:  1988-02       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.